2022 Finalists

Congratulations to the finalists who have been recognized by their peers for the inspiring work they do each day – all collectively working to make a difference for those living with and affected by cancer.

Please check back for updates and the announcement of winners in October 2022.


C2 Catalyst for Care Award

Finalists for this award bring high-quality cancer care to underserved populations. Consequently, their work drives change at the community-, neighborhood-, or hospital-level that results in better cancer care for more people.

Cancer Family Care

Represented by
Jill Settlemyre, MPA,
Executive Director

Sparrow’s Nest of the Hudson Valley

Represented by
Krista Jones,
Founder & Executive Director

Huntsman at Home

Represented by
Kathi Mooney, RN, PhD,
Co-Leader of Cancer Control and Population Sciences, Huntsman Cancer Institute


C2 Catalyst for Change Award

Finalists for this award significantly improve care for people with cancer and their loved ones. As a result, the work of these finalists makes people’s experience as easy as possible during an extraordinarily difficult time.

Thoracic Oncology Department at Baptist Cancer Center

Represented by
Nick Faris, MDiv,
Director of Thoracic Oncology, Baptist Cancer Center

Charles R. Rogers, PhD, MPH

Endowed Associate Professor,
Institute for Health & Equity at the Medical College of Wisconsin

Marianne T. Ritchie, MD

Clinical Associate Professor of Medicine,
Sidney Kimmel Medical College at Thomas Jefferson University Hospital


C2 Catalyst for Equity Award

Finalists for this award have worked to overcome longstanding racial and ethnic disparities in cancer care, ensuring that all people have equitable access to quality care.

Center for HOPE

Represented by
David Wetter, PhD,
Director of the Center for Health Outcomes & Population Equity (HOPE) at the University of Utah

Nina Bickell, MD, MPH

Health Delivery Research Core Director,
Institute for Health Equity Research at Icahn School of Medicine, Mount Sinai

Kathy Levy

Director of Community Awareness & Prevention Programs,
GO2 Foundation for Lung Cancer


C2 Catalyst for Precision Medicine Award

Finalists for this award significantly advance precision medicine in oncology to bring new, more personalized tests or treatments to people with cancer. As such, these finalists enhance the ability to provide the right treatment for the right patient at the right time.

Alana Welm, PhD

Senior Director of Basic Science,
Huntsman Cancer Center

Mark E. Burkard, MD, PhD

Mary & Rob Gooze Chair,
University of Wisconsin-Madison

Marc R. Matrana, MD

Director of Precision Medicine,
Ochsner Health


2022 C2 Awards

Click to learn more about the 2022 C2 Awards

×

You are now leaving yourcancer.org

You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.

AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.

Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed.

Cancel Confirm